Published in ScientificWorldJournal on January 09, 2014
Effect of Pulsed Electromagnetic Field on Bone Formation and Lipid Metabolism of Glucocorticoid-Induced Osteoporosis Rats through Canonical Wnt Signaling Pathway. Evid Based Complement Alternat Med (2016) 0.79
The protective effect of Rhizoma Dioscoreae extract against alveolar bone loss in ovariectomized rats via regulating Wnt and p38 MAPK signaling. Nutrients (2014) 0.76
Rhizoma Dioscoreae extract protects against alveolar bone loss in ovariectomized rats via microRNAs regulation. Nutrients (2015) 0.75
Effect of icariin on fracture healing in an ovariectomized rat model of osteoporosis. Exp Ther Med (2017) 0.75
Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res (1987) 24.27
Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res (2010) 9.95
Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med (2006) 7.46
The complex world of WNT receptor signalling. Nat Rev Mol Cell Biol (2012) 3.16
Menopausal hormone therapy and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2007) 2.55
Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med (Berl) (2005) 2.48
Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-kappa B ligand (RANKL). J Biol Chem (2000) 2.18
Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat Genet (2005) 2.10
The laboratory rat as an animal model for osteoporosis research. Comp Med (2008) 1.97
Efficacy of bazedoxifene in reducing new vertebral fracture risk in postmenopausal women with osteoporosis: results from a 3-year, randomized, placebo-, and active-controlled clinical trial. J Bone Miner Res (2008) 1.79
Purification and identification of a major activator for p38 from osmotically shocked cells. Activation of mitogen-activated protein kinase kinase 6 by osmotic shock, tumor necrosis factor-alpha, and H2O2. J Biol Chem (1996) 1.55
p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function. Endocrinology (2002) 1.52
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Wnt signaling in bone metabolism. J Bone Miner Metab (2009) 1.48
Determinants of incident vertebral fracture in men and women: results from the European Prospective Osteoporosis Study (EPOS). Osteoporos Int (2003) 1.45
Case-control study of postmenopausal hormone replacement therapy and endometrial cancer. Am J Epidemiol (2006) 1.27
A prospective study of postmenopausal hormone use and ovarian cancer risk. Br J Cancer (2006) 1.23
Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture. J Bone Miner Res (2003) 1.20
The role of Chinese medicine in the treatment of chronic diseases in China. Planta Med (2011) 1.13
Transcriptional regulation of bone and joint remodeling by NFAT. Immunol Rev (2010) 1.06
Raloxifene: a review of its use in postmenopausal osteoporosis. Drugs (2000) 1.03
Dried plum reverses bone loss in an osteopenic rat model of osteoporosis. Menopause (2005) 0.97
The use of estrogen, DHEA, and diosgenin in a sustained delivery setting as a novel treatment approach for osteoporosis in the ovariectomized adult rat model. Biomed Sci Instrum (2001) 0.97
Physiological bases of bone regeneration I. Histology and physiology of bone tissue. Med Oral Patol Oral Cir Bucal (2006) 0.96
Osteoporosis in men and women: a story about bone mineral density thresholds and hip fracture risk. J Bone Miner Res (2002) 0.95
High-resolution Micro-CT evaluation of mid- to long-term effects of estrogen deficiency on rat trabecular bone. Acad Radiol (2003) 0.93
Hormone replacement therapy and endometrial cancer in Ontario, Canada. J Clin Epidemiol (2000) 0.92
National Osteoporosis Society's Position statement on hormone replacement therapy in the prevention and treatment of osteoporosis. Menopause Int (2011) 0.89
P38 mitogen-activated protein kinase inhibitor, FR167653, inhibits parathyroid hormone related protein-induced osteoclastogenesis and bone resorption. PLoS One (2011) 0.89
Effects of ovariectomy on the changes in microarchitecture and material level properties in response to hind leg disuse in female rats. Bone (2012) 0.86
Aqueous extract of danshen (Salvia miltiorrhiza Bunge) protects ovariectomized rats fed with high-fat diet from endothelial dysfunction. Menopause (2013) 0.85
Cot kinase promotes Ca2+ oscillation/calcineurin-independent osteoclastogenesis by stabilizing NFATc1 protein. Mol Cell Biol (2012) 0.85
Differential maintenance of cortical and cancellous bone strength following discontinuation of bone-active agents. J Bone Miner Res (2011) 0.84
Semen Astragali Complanati- and Rhizoma Cibotii-enhanced bone formation in osteoporosis rats. BMC Complement Altern Med (2013) 0.80
Osteoprotective effect of Monascus-fermented dioscorea in ovariectomized rat model of postmenopausal osteoporosis. J Agric Food Chem (2011) 0.79
Simultaneous determination of allantoin, choline and L-arginine in Rhizoma Dioscoreae by capillary electrophoresis. J Chromatogr A (2004) 0.79
Effect of Curcumin on the Diversity of Gut Microbiota in Ovariectomized Rats. Nutrients (2017) 0.75